1. Wieland DM, Brown LE, Rogers WL, Worthington KC, Clinthorne NH, Otto CA, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog.J Nucl Med 1981; 22:22–31.
2. Nakajo M, Shaprio B, Glowinak J, Sisson JC, Beiermaltes WH. Inverse relationship between cardiac accumulation of meta-[131]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.J Nucl Med 1983; 24: 1127–1134.
3. Dae MW, O'Connell W, Botvinick E, Abearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation.Circulation 1989; 79:634–644.
4. Meriet P, Valette H, Dubois-Rand JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.J Nucl Med 1992; 33:471–477.
5. Mätysaari M, Kuikka J, Mustonen J, Tahvanainam K, Vannien E, Länstmies E, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I] Metaiodobenzyl guanidine.Diabetes 1992; 41:1069–1075.